Organic small molecular theranostic drug development

Develop optical/radioactive small molecular probes for disease earlier detection and treatment. Our group focus on NIR-II fluorescent (1000-1700 nm) and PET imaging theranostic probe development.

Using modern molecular imaging technology for multi-target/complex pharmacology drug development

The organism is a complex system. Using proteins and cells to screen drugs is increasingly unsatisfactory with current drug research. Our group develops cheap in vivo imaging methods for multi-target/ complex pharmacology drug development.

New NIR-II/SWIR fluorescent imaging system development

Our group develops new NIR-II fluorescent imaging systems for cheap, fast, high throughput in vivo imaging. Those setups can be used for theranostic drug development and pharmacodynamics evaluation.